Business
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether certai...
About this update from Caprock Mining Corp
[{"type":"text","content":"Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Atkore Inc. (ATKR), Axsome Therapeutics, Inc. (AXSM), Capricor Therapeutics, Inc. (CAPR), and CTO Realty Growth, Inc. (CTO)\nSAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether certain officers and directors of Atkore Inc. (NYSE: ATKR), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Capricor Therapeutics, Inc. (NASDAQ: CAPR), and CTO Realty Growth, Inc. (NYSE: CTO) breached the fiduciary duties they owed to the Company. Shareholders who have held shares continuously since prior to the dates listed below may have standing to seek corporate governance reforms, the return of funds to the Company, and a court-approved incentive award, at no cost to them. Atkore Inc. (NYSE: ATKR) If you have held Atkore shares continuously since prior to February 1, 2024, you may have standing to seek corporate governance reforms at Atkore, including improvements to internal controls, transparency, and executive oversight. To learn more, visit:https://www.johnsonfistel.com/investigations/atkore-inc/or contact Johnson Fistel, PLLP at [email protected] or (619) 814-4471. Complaint AllegationsA previously filed federal securities class action complaint alleges that: (1) Atkore engaged in an anticompetitive price-fixing scheme with other U.S.-based PVC pipe manufacturers to artificially inflate the price of PVC pipes; (2) Atkore gained significant, unsustainable financial benefits from such conduct; (3) when the anticompetitive price-fixing scheme was exposed, Atkore and its co-conspirators could no longer artificially inflate the price of PVC pipes, resulting in a dramatic decline in PVC pipe pricing; and (4) Atkore’s business and operations were negatively impacted. Axsome Therapeutics, Inc. (NASDAQ: AXSM) If you have held Axsome Therapeutics shares continuously since prior to May 10, 2021, you may have standing to seek corporate governance reforms at Axsome, including improvements to internal controls, transparency, and executive oversight. To learn more, visit:https://www.johnsonfistel.com/investigations/axsome-therapeutics-inc/or contact Johnson Fistel, PLLP at [email protected] or (619) 814-4471. Complaint AllegationsA previously filed securities class action complaint alleges that defendants touted AXS-07’s regu...